Previous 10 | Next 10 |
2023-11-03 10:08:44 ET More on Smith & Nephew Smith & Nephew: Exorbitant NWC Requirements To Maintain Competitive Position Smith & Nephew Getting More Interesting As A Contrarian Idea Dividend scorecard for Smith & Nephew For further details s...
2023-10-27 11:29:18 ET Summary Q3 results were impacted by customer returns related to the Boston facility recall, but the Codman Specialty Surgical business performed well. The reopening of the Boston facility is on track, but facility remediation can be a complicated process, an...
2023-10-13 08:00:00 ET Summary Smith & Nephew plc has experienced a sharp sell-off following its Q2 numbers, with the stock falling below its 200DMA. SNN is a capital-hungry business that requires significant reinvestment into working capital to maintain its competitive positi...
2023-10-12 16:31:15 ET Summary Smith & Nephew's shares have fallen over 20% this summer, despite ongoing improvements in the company's operations, as ortho stocks have been especially weak. The impact of GLP-1 drugs on the knee replacement market is uncertain; reduced obesity ...
Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich Canada NewsWire LONDON , Oct. 11, 2023 /CNW/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced ...
2023-08-04 02:39:09 ET Smith & Nephew plc (SNN) Q2 2023 Earnings Conference Call August 3, 2023 03:30 ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Jack Reyno...
2023-08-03 08:26:03 ET Smith & Nephew press release ( NYSE: SNN ): 1H Non-GAAP EPS of $0.35. Revenue of $2.73B (+5.0% Y/Y). Our first half revenue was $2,734 million (H1 2022: $2,600 million), up 7.3% on an underlying basis and up 5.2% on a reported basis, includin...
2023-08-01 04:44:27 ET Summary Smith & Nephew plc is a long-standing company in the medical device sector, focusing on developing and manufacturing internationally. The company has recently received FDA clearance for its AETOS Shoulder System, aiming to gain market share in th...
2023-07-14 04:30:00 ET Summary Fiduciary Management, Inc. is an independent money management firm. FMI’s equity investing strategies apply a value discipline, with a focused approach firmly rooted in fundamental research. FMI’s Small Cap and International Strategies ...
2023-06-29 05:08:31 ET Morgan Stanley is making some moves in its model for income-focused investors. It is adding two new positions with Rio Tinto ( NYSE: RIO ) and Smith & Nephew ( SNN ), swapping out Amgen ( AMGN ) and the iShares MSCI Hong Kong ETF ( EWH ). ...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...